Business Context and Reporting Period
Company: Gyrodyne, LLC (GYRO)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2025
Accounting Basis: Liquidation Basis of Accounting (imminent dissolution)
Strategy: The Company is in the process of liquidating its assets to maximize shareholder distributions. Its primary focus is pursuing entitlements and regulatory approvals for two remaining properties—Flowerfield (St. James, NY) and Cortlandt Manor (Cortlandt Manor, NY)—to enhance their value before sale. The Company intends to dissolve after asset disposition and debt settlement.
Key Financial Metrics
| Metric | June 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Real Estate Held for Sale | $54,890,000 | $50,388,000 |
| Cash and Cash Equivalents | $5,480,958 | $5,899,232 |
| Total Assets | $60,522,637 | $56,660,091 |
| Total Liabilities | $27,913,772 | $26,063,778 |
| Net Assets in Liquidation | $32,608,865 | $30,596,313 |
| Estimated Distribution Per Share | $14.83 | $13.91 |
| Loans Payable | $11,020,200 | $11,169,922 |
Note: The Company does not report traditional revenue or profit margins due to the liquidation basis of accounting. Instead, it reports changes in net assets based on estimated realizable values and liquidation costs.
Material Changes vs. Prior Period
- Net Assets Increase: Net assets in liquidation increased by $2,012,552 (6.6%) from December 31, 2024.
- Real Estate Valuation: The liquidation value of real estate increased by $4,502,000, driven by updated appraisals and market conditions.
- Operating Activity: Net operating income from leasing activity contributed approximately $252,000 to the increase in net assets.
- Cost Adjustments: The increase was partially offset by a remeasurement of assets and liabilities totaling $(2,489,448). This included an estimated $2,257,000 increase in liquidation and operating costs due to a one-year timeline extension, plus $446,000 in additional selling and retention bonus costs.
- Cash Position: Cash decreased by approximately $418,000, primarily due to operating expenditures and debt service.
Guidance, Outlook, and Risks
Outlook and Timeline
The Company estimates the liquidation process will culminate in 2027. This timeline assumes the resolution of ongoing legal proceedings and the receipt of necessary regulatory approvals. Management anticipates subdivision approval for Flowerfield in Q4 2025 and for Cortlandt Manor in late 2026.
Material Subsequent Event
On July 30, 2025, the Company entered into a Purchase and Sale Agreement to sell approximately 49 acres of the Flowerfield property to B2K Smithtown LLC. The purchase price is estimated between $24,000,000 and $28,740,000, contingent on subdivision and site plan approvals. Closing is estimated no later than December 2027.
Risks and Contingencies
- Article 78 Proceeding: An ongoing legal challenge by the Village of Head of the Harbor seeks to annul the preliminary subdivision approval for Flowerfield. While the Supreme Court dismissed the petition in October 2024, petitioners have appealed. The outcome remains uncertain and could delay sales.
- Regulatory Delays: Backlogs in land use applications, zoning authority labor shortages, and environmental concerns may extend the timeline beyond 2027.
- Activist Shareholders: Star Equity Fund (approx. 7.1% owner) has nominated candidates for the Board, potentially leading to a contested election at the 2025 Annual Meeting.
- Liquidity: The Company has approximately 18 months of cash runway absent asset sales. It relies on rental income and potential loan modifications to fund operations through liquidation.
Investor Verification Checklist
- Legal Status of Article 78 Proceeding: Verify the current status of the appeal regarding the Flowerfield subdivision approval, as this is a primary blocker to the B2K sale.
- B2K Agreement Contingencies: Review the specific conditions for the $24M-$28.7M sale, particularly the timeline for obtaining site plan approvals and the buyer's right to terminate.
- Liquidation Cost Estimates: Assess the sensitivity of the $14.83 per share distribution estimate to changes in the liquidation timeline (currently projected to 2027) and entitlement costs.
- Shareholder Activism: Monitor the outcome of the proxy contest with Star Equity Fund and potential changes to the Board composition or strategic direction.
- Debt Covenants: Confirm the Company's compliance with loan covenants and the feasibility of extending loan maturities to align with the 2027 liquidation target.